Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids

Bile salt biotransformations by human intestinal bacteria

Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829

Burden of Clostridium difficile Infection in the United States

Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408913 · Cited by 2,641

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist

Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331

The Enzymes, Regulation, and Genetics of Bile Acid Synthesis

Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069

An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile

McDonald, L. C., Killgore, G., Thompson, A. D., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,020

Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile

Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872

Bile acids: regulation of synthesis

Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,515

Clostridium difficile Infection

Leffler, D. A., & LaMont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,501

Clostridium difficile infection: new developments in epidemiology and pathogenesis

Rupnik, M., Wilcox, M. H., & Gerding, D. N. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2164 · Cited by 1,380 · cited 1×

Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection

Theriot, C. M., Koenigsknecht, M. J., Carlson, P. E., Hatton, G. E., Nelson, A. M., Li, B., Huffnagle, G. B., Z. Li, J., & Young, V. B. (2014) · Nature Communications · doi:10.1038/ncomms4114 · Cited by 974

Impact of deoxycholate on Clostridioides difficile growth, toxin production, and sporulation

Usui, Y., Ayibieke, A., Kamiichi, Y., Okugawa, S., Moriya, K., Tohda, S., & Saito, R. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03717 · Cited by 21

Computational modeling of the gut microbiota reveals putative metabolic mechanisms of recurrent Clostridioides difficile infection

Henson, M. A. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008782 · Cited by 19

Impact of Primary and Secondary Bile Acids on Clostridioides difficile Infection

Łukawska, A., & Mulak, A. (2022) · Polish Journal of Microbiology · doi:10.33073/pjm-2022-007 · Cited by 20

Epidemiological and microbiome associations of Clostridioides difficile carriage in infancy and early childhood

Mani, J., Levy, S., Angelova, A. G., Hazrati, S., Fassnacht, R., Subramanian, P., Richards, T., Niederhuber, J. E., Maxwell, G. L., & Hourigan, S. K. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2203969 · Cited by 20

Dissecting Individual Interactions between Pathogenic and Commensal Bacteria within a Multispecies Gut Microbial Community

Hassall, J., Cheng, J. K. J., & Unnikrishnan, M. (2021) · mSphere · doi:10.1128/msphere.00013-21 · Cited by 20

Prevalence of Clostridioides difficile in Canine Feces and Its Association with Intestinal Dysbiosis

Werner, M., Ishii, P. E., Pilla, R., Lidbury, J. A., Steiner, J. M., Busch, K., Unterer, S., & Suchodolski, J. S. (2023) · Animals · doi:10.3390/ani13152441 · Cited by 19

Clostridium scindens secretome suppresses virulence gene expression of Clostridioides difficile in a bile acid-independent manner

Saenz, C., Fang, Q., Gnanasekaran, T., Trammell, S. A. J., Buijink, J. A., Pisano, P., Wierer, M., Moens, F., Lengger, B., Brejnrod, A., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03933-22 · Cited by 18

Alcohol-induced gut microbiome dysbiosis enhances the colonization of Klebsiella pneumoniae on the mouse intestinal tract

Shen, M., Zhao, H., Han, M., Su, L., Cui, X., Duan, L., Liu, L., Wang, C., & Yang, F. (2024) · mSystems · doi:10.1128/msystems.00052-24 · Cited by 21

Regulatory functions and mechanisms of human microbiota in infectious diseases

Fang, Y., Lei, Z., Zhang, L., Liu, C. H., & Chai, Q. (2024) · hLife · doi:10.1016/j.hlife.2024.03.004 · Cited by 20

Bile salt metabolism is not the only factor contributing toClostridioides(Clostridium)difficiledisease severity in the murine model of disease

Jukes, C., Ijaz, U. Z., Buckley, A. M., Spencer, J., Irvine, J. J., Candlish, D., Li, J. V., Marchesi, J. R., & Douce, G. R. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1678996 · Cited by 17

Metabolic tug-of-war: Microbial metabolism shapes colonization resistance against enteric pathogens

Jones, K., de Brito, C. B., & Byndloss, M. X. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2024.12.005 · Cited by 20

The role and therapeutic potential of gut microbiome in severe burn

Huang, Z., Huang, Y., Chen, J., Tang, Z., Chen, Y., Liu, H., Huang, M., Qing, L., Li, L., Wang, Q. L., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.974259 · Cited by 20

Identification of a Bile Acid-Binding Transcription Factor in Clostridioides difficile Using Chemical Proteomics

Forster, E. R., Yang, X., Tai, A., Hang, H. C., & Shen, A. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00463 · Cited by 19

Microbiome and Metabolome Restoration After Administration of Fecal Microbiota, Live-jslm (REBYOTA) for Preventing Recurrent Clostridioides difficile Infection

Blount, K., Papazyan, R., Ferdyan, N., Srinivasan, K., Gonzalez, C., Shannon, W. D., & Fuchs, B. C. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae418 · Cited by 17

Insights into the Interaction Between Clostridioides difficile and the Gut Microbiome

Mougiou, D., Gioula, G., Skoura, L., Anastassopoulou, C. G., & Kachrimanidou, M. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15030094 · Cited by 18

Microbial bile acid modifications: current understandings, key problems, and future perspectives

Zhang, H., Wen, J., Liu, X., Feng, Y., Liu, X., & Ning, K. (2025) · Science China Life Sciences · doi:10.1007/s11427-025-3019-2 · Cited by 20

Fecal microbiota transplants: A review of emerging clinical data on applications, efficacy, and risks (2015–2020)

Al‐Ali, D., Ahmed, A., Shafiq, A., McVeigh, C., Châari, A., Zakaria, D., & Bendriss, G. (2021) · Qatar medical journal · doi:10.5339/qmj.2021.5 · Cited by 19

Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis

Pike, C. M., Tam, J., Melnyk, R. A., & Theriot, C. M. (2022) · Infection and Immunity · doi:10.1128/iai.00153-22 · Cited by 18

Host and microbial-derived metabolites for Clostridioides difficile infection: Contributions, mechanisms and potential applications

Gao, Y., Ma, L., & Su, J. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127113 · Cited by 17

Clostridioides difficile infection: traversing host–pathogen interactions in the gut

Cheng, J. K. J., & Unnikrishnan, M. (2023) · Microbiology · doi:10.1099/mic.0.001306 · Cited by 16

Underneath the Gut–Brain Axis in IBD—Evidence of the Non-Obvious

Boldyreva, L. V., Evtushenko, A. A., Lvova, M. N., Morozova, K. N., & Владимировна, К. Е. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212125 · Cited by 16

Microbiota-associated Risk Factors for Clostridioides difficile Acquisition in Hospitalized Patients: A Prospective, Multicentric Study

Solbach, P., Chhatwal, P., Woltemate, S., Tacconelli, E., Buhl, M. E. J., Autenrieth, I. B., Vehreschild, M. J. G. T., Jazmati, N., Gerhard, M., Stein‐Thoeringer, C. K., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa871 · Cited by 16

Clostridioides difficile carriage in animals and the associated changes in the host fecal microbiota

Thanissery, R., McLaren, M. R., Rivera, A. J., Reed, A. D., Betrapally, N. S., Burdette, T., Winston, J. A., Jacob, M. E., Callahan, B. J., & Theriot, C. M. (2020) · Anaerobe · doi:10.1016/j.anaerobe.2020.102279 · Cited by 21

Capsules for Fecal Microbiota Transplantation in Recurrent Clostridium difficile Infection

Rao, K. K., Young, V. B., & Malani, P. (2017) · JAMA · doi:10.1001/jama.2017.17969 · Cited by 16

Microbiome-Targeted Therapies in Gastrointestinal Diseases: Clinical Evidence and Emerging Innovations

Lim, E. C. N., & Lim, C. E. D. (2025) · Acta Microbiologica Hellenica · doi:10.3390/amh70030036 · Cited by 19

Assessing the clinical value of faecal bile acid profiling to predict recurrence in primary Clostridioides difficile infection

Mullish, B. H., Martínez-Gili, L., Chekmeneva, E., Correia, G. D. S., Lewis, M. R., der Sluis, V. H.-V., Roberts, L. A., McDonald, J. A. K., Pechlivanis, A., Walters, J. R. F., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17247 · Cited by 15

Intestinal bile acids provide a surmountable barrier against C. difficile TcdB-induced disease pathogenesis

Icho, S., Ward, J. S., Tam, J., Kociolek, L. K., Theriot, C. M., & Melnyk, R. A. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2301252120 · Cited by 15

Potential biomarkers to predict outcome of faecal microbiota transfer for recurrent Clostridioides difficile infection

Farowski, F., Solbach, P., Tsakmaklis, A., Brodesser, S., Aguilar, M. R. C., Cornely, O. A., Dettmer, K., Higgins, P. G., Suerbaum, S., Jazmati, N., et al. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.01.012 · Cited by 15

Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treating Clostridioides difficile infection: A randomized controlled trial

Chitapanarux, T., Wiracha, U., Winichakoon, P., Salee, P., & Traisathit, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-04986-2 · Cited by 16

The Novel DNA Binding Mechanism of Ridinilazole, a Precision Clostridiodes difficile Antibiotic

Mason, C., Avis, T., Hu, C., Nagalingam, N. A., Mudaliar, M., Coward, C., Begum, K., Gajewski, K. M., Alam, M. J., Bassères, E., et al. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01563-22 · Cited by 14

Two Acinetobacter baumannii Isolates Obtained From a Fatal Necrotizing Fasciitis Infection Display Distinct Genomic and Phenotypic Characteristics in Comparison to Type Strains

Grier, J. T., Arivett, B. A., Ramirez, M. S., Chosed, R. J., Bigner, J. A., Ohneck, E. J., Metz, M. L., Wood, C. R., Arce, S., Tartaro, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.635673 · Cited by 14

Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection

Feuerstadt, P., Hong, S. J., & Brandt, L. J. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05804-2 · Cited by 13

Secondary (iso)BAs cooperate with endogenous ligands to activate FXR under physiological and pathological conditions

Zaufel, A., van de Wiel, S. M. W., Yin, L., Fauler, G., Chien, D. C.-C., Dong, X., Gilmer, J. F., Truong, J. K., Dawson, P. A., van de Graaf, S. F. J., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166153 · Cited by 14

Toward the development of defined microbial therapeutics

Li, Y., & Honda, K. (2021) · International Immunology · doi:10.1093/intimm/dxab038 · Cited by 13

Clostridioides difficile infection: microbe-microbe interactions and live biotherapeutics

Wang, R. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1182612 · Cited by 14

tDCS Regulates ASBT-3-OxoLCA-PLOD2-PTEN Signaling Pathway to Confer Neuroprotection Following Rat Cerebral Ischemia-Reperfusion Injury

Kong, X., Yao, X., Ren, J., Gao, J., Cui, Y., Sun, J., Xu, X., Hu, W., Wang, H., Li, H., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03504-7 · Cited by 13

Learning ecosystem-scale dynamics from microbiome data with MDSINE2

Gibson, T. E., Kim, Y., Acharya, S., Kaplan, D. E., DiBenedetto, N., Lavin, R., Berger, B., Allegretti, J. R., Bry, L., & Gerber, G. K. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02112-6 · Cited by 15

Detection and elimination of a novel non-toxigenic Clostridioides difficile strain from the microbiota of a mouse colony

Maslanka, J. R., Gu, C. H., Zarin, I., Denny, J. E., Broadaway, S. C., Fett, B., Mattei, L. M., Walk, S. T., & Abt, M. C. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1851999 · Cited by 12

Current and Future Therapeutic Options for Irritable Bowel Syndrome with Diarrhea and Functional Diarrhea

Ramos, G. P., & Camilleri, M. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07700-8 · Cited by 14

Microbiome therapeutics for the treatment of recurrent Clostridioides difficile infection

Bloom, P. P., & Young, V. B. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2154600 · Cited by 12

Longitudinal Bile Acid Composition Changes Following Faecal Microbiota Transplantation for Clostridioides difficile Infection in Children With and Without Underlying Inflammatory Bowel Disease

Chen, L. A., Oliva‐Hemker, M. M., Radin, A. S., Weidner, M., O’Laughlin, B., Sears, C. L., Javitt, N. B., & Hourigan, S. K. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad057 · Cited by 12

Metabolomic signatures of intestinal colonization resistance against Campylobacter jejuni in mice

Shayya, N. W., Bandick, R., Busmann, L. V., Mousavi, S., Bereswill, S., & Heimesaat, M. M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1331114 · Cited by 12

Destination and Specific Impact of Different Bile Acids in the Intestinal Pathogen Clostridioides difficile

Metzendorf, N. G., Lange, L. M., Lainer, N., Schlüter, R., Dittmann, S., Paul, L.-S., Troitzsch, D., & Sievers, S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.814692 · Cited by 14

In vivo animal models confirm an increased virulence potential and pathogenicity of the NAP1/RT027/ST01 genotype within the Clostridium difficile MLST Clade 2

Orozco-Aguilar, J., Alfaro-Alarcón, A., Acuña-Amador, L., Chaves‐Olarte, E., Rodríguez, C., & Quesada-Gómez, C. (2020) · Gut Pathogens · doi:10.1186/s13099-020-00383-4 · Cited by 11

The Role of Cyclomodulins and Some Microbial Metabolites in Bacterial Microecology and Macroorganism Carcinogenesis

Markelova, N. N., Semenova, E. F., Синева, О. Н., & Sadykova, V. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911706 · Cited by 12

Intestinal microecology dysbiosis in inflammatory bowel disease: Pathogenesis and therapeutic strategies

Yin, Y., Feng, W., Chen, X., Chen, J., Wang, G., Xia, L., & Wu, K. (2024) · The Innovation Medicine · doi:10.59717/j.xinn-med.2024.100092 · Cited by 11

Human fecal metabolomic profiling could inform Clostridioides difficile infection diagnosis and treatment

Theriot, C. M., & Fletcher, J. R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130008 · Cited by 10

Differential modulation of post-antibiotic colonization resistance to Clostridioides difficile by two probiotic Lactobacillus strains

Foley, M. H., McMillan, A. S., O’Flaherty, S., Thanissery, R., Vanhoy, M. E., Fuller, M. G., Barrangou, R., & Theriot, C. M. (2025) · mBio · doi:10.1128/mbio.01468-25 · Cited by 13

Bioactivities, Mechanisms, Production, and Potential Application of Bile Acids in Preventing and Treating Infectious Diseases

Liu, S., Yang, S., Blažeković, B., Lu, L., Zhang, J., & Wang, Y. N. (2024) · Engineering · doi:10.1016/j.eng.2023.11.017 · Cited by 10

Unique growth and morphology properties of Clade 5 Clostridioides difficile strains revealed by single-cell time-lapse microscopy

Ribis, J. W., Nieto, C., DiBenedetto, N., Mehra, A., Kuhn, P., Dong, Q., Nagawa, I., Meouche, I. E., Aldridge, B. B., Dunlop, M. J., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013155 · Cited by 7

Pterostilbene attenuates intestinal barrier damage and secondary liver oxidative stress in a murine model of Clostridium difficile infection by regulating the gut microbiota

Yang, H., Kuang, Y., Wang, L., Ma, X., Villafuerte-Gálvez, J., Lu, J., Dai, Y., Liu, S., Yao, J., Chen, X., et al. (2025) · Food & Function · doi:10.1039/d4fo06413e · Cited by 9

Altered iso- and oxo-Fecal Bile Acid Concentrations in Dogs with Chronic Enteropathy

Blake, A. B., Toresson, L., Chen, C.-C., Ishii, P. E., Phillips, R. K., Giaretta, P. R., Cavasin, J. P., Lidbury, J. A., & Suchodolski, J. S. (2025) · Pets · doi:10.3390/pets2020018 · Cited by 14

Host origin of microbiota drives functional recovery and Clostridioides difficile clearance in mice

Millard, S., Vendrov, K. C., Young, V. B., & Seekatz, A. M. (2025) · mBio · doi:10.1128/mbio.01108-25 · Cited by 10

The interplay between host immunity and Clostridioides difficile infection

Li, D., & Saavedra, P. H. V. (2025) · mBio · doi:10.1128/mbio.03562-24 · Cited by 9

Clostridioides difficile: innovations in target discovery and potential for therapeutic success

Monaghan, T. M., Seekatz, A. M., Mullish, B. H., Moore-Gillon, C., Dawson, L. F., Ahmed, A. E., Kao, D. H., & Chan, W. C. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.2008907 · Cited by 9

Offline Two-Dimensional Liquid Chromatography–Mass Spectrometry for Deep Annotation of the Fecal Metabolome Following Fecal Microbiota Transplantation

Anderson, B. G., Raskind, A. B., Hissong, R., Dougherty, M., McGill, S., Gulati, A., Theriot, C. M., Kennedy, R. T., & Evans, C. R. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00022 · Cited by 9

Effects of Postbiotic from Bacteriocin-Like Inhibitory Substance Producing Enterococcus faecalis on Toxigenic Clostridioides difficile

Luenglusontigit, P., Sathapondecha, P., Saengsuwan, P., Surachat, K., Boonserm, P., & Singkhamanan, K. (2023) · Journal of Health Science and Medical Research · doi:10.31584/jhsmr.2023918 · Cited by 8

Viewing Bacterial Colonization through the Lens of Systems Biology

Barron, M. R., & Young, V. B. (2022) · mSystems · doi:10.1128/msystems.01383-21 · Cited by 9

In vivo commensal control of Clostridioides difficile virulencePreprint

Girinathan, B. P., DiBenedetto, N., Worley, J. N., Johann, P., Arrieta-Ortiz, M. L., Immanuel, R., Lavin, R., Delaney, M. L., Cummins, C., Hoffmann, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.04.894915 · Cited by 7

Microbial dynamics inference at ecosystem-scalePreprint

Gibson, T. E., Kim, Y., Acharya, S., Kaplan, D. E., DiBenedetto, N., Lavin, R., Berger, B., Allegretti, J. R., Bry, L., & Gerber, G. K. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.14.469105 · Cited by 8

Effect of sub-MIC of vancomycin and clindamycin alone and in combination with ceftazidime on Clostridium difficile surface layer protein A (slpA) gene expression

Zarandi, E. R., Mansouri, S., Nakhaee, N., Sarafzadeh, F., & Moradi, M. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.08.034 · Cited by 7

Investigating the transient and persistent effects of heat on Clostridium difficile spores

Pickering, D. S., Vernon, J. J., Freeman, J., Wilcox, M. H., & Chilton, C. H. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001048 · Cited by 7

Descriptive Study of Gut Microbiota in Infected and Colonized Subjects by Clostridiodes difficile

Sánchez-Pellicer, P., Navarro‐López, V., González-Tamayo, R., Llopis-Ruiz, C., Núñez-Delegido, E., Ruzafa-Costas, B., Navarro-Moratalla, L., & Agüera-Santos, J. (2021) · Microorganisms · doi:10.3390/microorganisms9081727 · Cited by 8

Saccharomyces boulardii prophylaxis for targeted antibiotics and infectious indications to reduce healthcare facility-onset Clostridioides difficile infection

Wombwell, E. (2022) · Microbes and Infection · doi:10.1016/j.micinf.2022.105041 · Cited by 7

Listening in on the conversation between the human gut microbiome and its host

Lin, W., Djuković, A., Mathur, D., & Xavier, J. B. (2021) · Current Opinion in Microbiology · doi:10.1016/j.mib.2021.07.009 · Cited by 7

Mechanism of germination inhibition of Clostridioides difficile spores by an aniline substituted cholate derivative (CaPA)

Yip, C., Phan, J. R., & Abel‐Santos, E. (2023) · The Journal of Antibiotics · doi:10.1038/s41429-023-00612-3 · Cited by 6

Bile Acids and Farnesoid X Receptor in Renal Pathophysiology

Yang, J., Pontoglio, M., & Terzi, F. (2024) · The Nephron journals/Nephron journals · doi:10.1159/000538038 · Cited by 6

Dietary Supplementation of Crossbred Pigs with Glycerol, Vitamin C, and Niacinamide Alters the Composition of Gut Flora and Gut Flora-Derived Metabolites

Wei, P., Sun, W., Hao, S., Deng, L., Zou, W., Wu, H., Lü, W., & He, Y. (2024) · Animals · doi:10.3390/ani14152198 · Cited by 6

Investigating the effect of supplementation on Clostridioides (Clostridium) difficile spore recovery in two solid agars

Pickering, D. S., Vernon, J. J., Freeman, J., Wilcox, M. H., & Chilton, C. H. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2018.01.010 · Cited by 6

Clostridioides difficile Spores: Bile Acid Sensors and Trojan Horses of Transmission

Shen, A. (2020) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0040-1701230 · Cited by 8

Isoallolithocholic acid ameliorates intestinal inflammation via metabolically reprogrammed macrophages

Wang, Y., Yan, W., Zhao, H., Lu, Y., Li, Y., Peng, S., & Xiao, Y. (2025) · Communications Biology · doi:10.1038/s42003-025-09123-3 · Cited by 7

Novel insights into phage biology of the pathogen Clostridioides difficile based on the active virome

Schüler, M. A., Daniel, R., & Poehlein, A. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1374708 · Cited by 5

Assessment of independent comorbidities and comorbidity measures in predicting healthcare facility-onset Clostridioides difficile infection in Kenya

Mutai, W. C., Mureithi, M., Anzala, O. A., Kullin, B., Ofwete, R., Kyanya, C. K., Odoyo, E., Musila, L. A., & Revathi, G. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000090 · Cited by 5

Structure-guided design of a synthetic bile acid that inhibits Clostridioides difficile TcdB toxin

Miletic, S., Icho, S., Li, Z., Tam, J., Rose, E. C., Perkins, C. E., Nakhi, A., Yang, X., Hang, H. C., Rubinstein, J. L., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02179-1 · Cited by 5

Gut Microbial and Metabolic Features Associated With Clostridioides difficile Infection Recurrence in Children

Li, X., Xiao, F., Wang, X., Ye, L., Xiao, Y., Li, D., Zhang, T., & Wang, Y. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae506 · Cited by 7

Spatial analysis of murine microbiota and bile acid metabolism during amoxicillin treatment

Beekman, C. N., Penumutchu, S., Peterson, R., Han, G., Belenky, M., Hasan, M., Belenky, A., Beura, L. K., & Belenky, P. A. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114572 · Cited by 4

Douchi-derived Bacillus subtilis modulates gut microbiota and bile acid metabolism to alleviate metformin-induced diarrhea in type 2 diabetes mellitus

Wang, Q., Yang, M., Fang, Z., Pan, Y., Wu, Y., Yuan, Z., Xu, M., Chen, Y., & Gong, A. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107207 · Cited by 4

Distinct bile salt hydrolase substrate preferences dictate C. difficile pathogenesisPreprint

Foley, M. H., Walker, M. E., Stewart, A. K., O’Flaherty, S., Gentry, E. C., Allen, G. B., Patel, S., Pan, M., Beaty, V. V., Vanhoy, M. E., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.24.485529 · Cited by 4

Lotus seed resistant starch ameliorates blood lipid by regulating flora and promoting bile acids excretion in hyperlipidemic rats

Lei, S., Jiang, Y., Lin, Z., Zheng, B., Zhang, Y., & Zeng, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145742 · Cited by 4

Advances in Understanding the Pathogenesis of Clostridioides difficile Infection

Seekatz, A. M., & Abt, M. C. (2025) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2025.07.001 · Cited by 3

Fecal Metabolomics for the Diagnosis of Clostridioides difficile Infection

Serrano, C. B., Belmonte-Domingo, A., Pinto-Pla, C., Ferrer-Ribera, A., Vela, S., de Gracia-León, A. I., de Castro-Oliver, A., Serna-Navarro, L., Sirvent, C. P., Ruiz-Raga, D., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15182331 · Cited by 3

Probiotics as Anti-Giardia Defenders: Overview on Putative Control Mechanisms

Alazzaz, J., Chaouch, S., Boucard, A.-S., Bermúdez‐Humarán, L. G., & Florent, I. (2020) · Springer eBooks · doi:10.1007/978-3-030-44826-4_24 · Cited by 3

Characterization of C. difficile strains isolated from companion animals and the associated changes in the host fecal microbiotaPreprint

Thanissery, R., McLaren, M. R., Rivera, A. J., Reed, A. D., Betrapally, N. S., Burdette, T., Winston, J. A., Jacob, M. E., Callahan, B. J., & Theriot, C. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/822577 · Cited by 3

Clostridioides difficile infection study models and prospectives for probing the microbe-host interface

Zvonareva, T., Courson, D. S., & Purcell, E. B. (2025) · Journal of Bacteriology · doi:10.1128/jb.00407-24 · Cited by 3

Clostridioides difficile toxins alter host metabolic pathway and bile acid homeostasis gene expression in colonic epithelium

Thomas, S., Pike, C. M., Perkins, C. W., Brown, S., Jaen, X. M. E., McMillan, A. S., & Theriot, C. M. (2025) · Infection and Immunity · doi:10.1128/iai.00150-25 · Cited by 2

Lipidomics, Microbiota, and Intestinal Clostridioides difficile Infection Outcome

Branković, M., Kraišnik, M., Zdravković, D., Kraišnik, N., Jelić, F., Nikolić, N., Djurasevic, S. F., Tosti, T. B., Gmizić, T., & Todorović, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178214 · Cited by 2

The Ambivalent Nature of Bacteroides fragilis and the Interaction with Clostridioides difficile: Benefits and Disadvantages for the Human Host

Spigaglia, P. (2025) · Toxins · doi:10.3390/toxins17100513 · Cited by 2

Integrating bile acid metabolism into precision nutrition strategies for improved swine performance

Li, S., He, Y., Shaoyong, W., Wang, Y., & Jin, M. (2025) · Animal nutrition · doi:10.1016/j.aninu.2025.05.013 · Cited by 2

High-resolution metabolomic analysis of stool reveals expanded biomarkers of C. difficile colitis and insights into pathophysiology

Mehta, N., Guzzetta, V. S., Liu, K., Webster, A. S., Adelman, M. W., Fitts, E. C., Jones, D. P., Kraft, C. S., Woodworth, M. H., & Collins, J. M. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.02826-25 · Cited by 2

Potential Role of Microbiota in the Prevention and Therapeutic Management of Infectious Diseases

Shahid, A., Nasir, K., Aslam, S., Kamran, M., Sarfraz, M. H., Saleem, H. G. M., & Khurshid, M. (2022) · Pakistan Journal of Biochemistry and Biotechnology · doi:10.52700/pjbb.v3i1.75 · Cited by 3

Enhancing bezlotoxumab binding to C. difficile toxin B2: insights from computational simulations and mutational analyses for antibody design

Karnchanapandh, K., Sanachai, K., Poo-arporn, R. P., & Rungrotmongkol, T. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2329785 · Cited by 2

Current Status of Fecal Microbiota Transplantation

Reygner, J., & Kapel, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00016-6 · Cited by 2

Current treatments for recurrent Clostridium difficile infection

Kowalewski, J., Recka, K., Michałka, D., Grzelak, A., Jędrocha, O., Bęben, D., Godyńska, S., Obacz, E., Miliwek, J., & Grodek, Z. (2024) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/189968 · Cited by 1

CAT-GxD: Centralized access to gene expression datasets

Roxas, B. P., Roxas, J. L., Guo, J., LeBauer, D. S., McCarthy, F., Vedantam, G., & Viswanathan, V. K. (2025) · Anaerobe · doi:10.1016/j.anaerobe.2025.103005 · Cited by 1

The emergence and biological characteristics of linezolid-resistant Clostridioides difficile isolates in the Asia-Pacific region

Chen, Y., Chen, X., Xu, H., Shen, H., Liu, X., Wan, F., Han, Y., Song, X., Li, J., Du, H., et al. (2026) · Emerging Microbes & Infections · doi:10.1080/22221751.2026.2627070 · Cited by 1

Non-targeted metabolomics reveals metabolic signatures associated with Clostridioides difficile virulence

Pan, H., Zhang, M., Zhao, D., Wang, Q., Shang, H., & Luo, Y. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1731048 · Cited by 1

Dietary fiber reduces mortality from secondary sepsis in a murine model of Clostridioides difficile infection

Apgar, M., Wall, E. S., Kiela, P. R., Neff, C. P., Orlicky, D. J., Lyon, L. M., Bernardazzi, C., Martin, C. G., Gordon, O. M., Espinoza, I. J., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115258 · Cited by 2

Parabacteroides distasonis alleviates Clostridioides difficile infection in mice while modulating secondary bile acids

Zhao, M., Wen, B., Ouyang, Z., Yang, J. X., Yang, H., Jiafeng, Z., 强翠欣, Wang, W., Qin, P., Niu, Y., et al. (2026) · Virulence · doi:10.1080/21505594.2026.2697574 · Cited by 1

Systematic Review of Current Treatment and Prevention Strategies for Clostridium difficile

Parmar, N. V., & Glauser, J. M. (2019) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-019-00186-1 · Cited by 1

Antibiotic and Immunological Alternatives for the Management of Clostridioides difficile Infection

González-Carballo, G. C. (2024) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2024.07.1334 · Cited by 1

Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine

Theriot, C. M., Bowman, A. A., & Young, V. B. (2016) · mSphere · doi:10.1128/msphere.00045-15 · Cited by 481

Different bile acids have versatile effects on sporulation, toxin levels and biofilm formation of different Clostridioides difficile strains

Aias, M., Azrad, M., Saad, G., Leshem, T., Hamo, Z., Rahmoun, L. A., & Peretz, A. (2023) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2023.106692 · Cited by 7

Spores of Clostridium difficile Clinical Isolates Display a Diverse Germination Response to Bile Salts

Heeg, D., Burns, D. A., Cartman, S. T., & Minton, N. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032381 · Cited by 112

Das Wachstums- und Sporulationsverhalten klinischer Clostridioides-difficile-Isolate unter intestinalen Gallensalzkonzentrationen

Yilmaz, E. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8938

Reexamining the Germination Phenotypes of Several Clostridium difficile Strains Suggests Another Role for the CspC Germinant Receptor

Bhattacharjee, D., Francis, M. B., Ding, X., McAllister, K. N., Shrestha, R., & Sorg, J. A. (2015) · Journal of Bacteriology · doi:10.1128/jb.00908-15 · Cited by 58